1. Home
  2. NKGN vs TACT Comparison

NKGN vs TACT Comparison

Compare NKGN & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • TACT
  • Stock Information
  • Founded
  • NKGN 2017
  • TACT 1996
  • Country
  • NKGN United States
  • TACT United States
  • Employees
  • NKGN N/A
  • TACT N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • TACT Computer peripheral equipment
  • Sector
  • NKGN Health Care
  • TACT Technology
  • Exchange
  • NKGN Nasdaq
  • TACT Nasdaq
  • Market Cap
  • NKGN 37.8M
  • TACT 44.1M
  • IPO Year
  • NKGN N/A
  • TACT 1996
  • Fundamental
  • Price
  • NKGN $0.57
  • TACT $4.23
  • Analyst Decision
  • NKGN
  • TACT Strong Buy
  • Analyst Count
  • NKGN 0
  • TACT 1
  • Target Price
  • NKGN N/A
  • TACT $7.50
  • AVG Volume (30 Days)
  • NKGN 10.4M
  • TACT 10.0K
  • Earning Date
  • NKGN 04-15-2025
  • TACT 03-11-2025
  • Dividend Yield
  • NKGN N/A
  • TACT N/A
  • EPS Growth
  • NKGN N/A
  • TACT N/A
  • EPS
  • NKGN N/A
  • TACT N/A
  • Revenue
  • NKGN N/A
  • TACT $46,418,000.00
  • Revenue This Year
  • NKGN N/A
  • TACT N/A
  • Revenue Next Year
  • NKGN N/A
  • TACT $16.86
  • P/E Ratio
  • NKGN N/A
  • TACT N/A
  • Revenue Growth
  • NKGN N/A
  • TACT N/A
  • 52 Week Low
  • NKGN $0.20
  • TACT $3.32
  • 52 Week High
  • NKGN $4.06
  • TACT $7.25
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 52.48
  • TACT 39.81
  • Support Level
  • NKGN $0.40
  • TACT $4.30
  • Resistance Level
  • NKGN $0.91
  • TACT $4.48
  • Average True Range (ATR)
  • NKGN 0.13
  • TACT 0.20
  • MACD
  • NKGN 0.00
  • TACT -0.03
  • Stochastic Oscillator
  • NKGN 40.78
  • TACT 32.73

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: